Search

Your search keyword '"Yoshino, Tadashi"' showing total 1,985 results

Search Constraints

Start Over You searched for: Author "Yoshino, Tadashi" Remove constraint Author: "Yoshino, Tadashi"
1,985 results on '"Yoshino, Tadashi"'

Search Results

2. Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

6. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

9. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

10. A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial

14. PD-L1 expression in tongue squamous cell carcinoma

18. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling

20. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

22. Effect of a Cyclooxygenase-2 Inhibitor in Combination with (−)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

23. Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype

24. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements

25. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

32. Supplementary Fig. from Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines

33. Supplementary Data from Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

35. Supplementary Figure 1 from Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

36. Supplementary Figure 2 from Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

37. Supplementary Figure Legends 1-2 from Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

38. Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy

40. Prolonged Cytopenia after CAR-T Cell Therapy Is Associated with BM Niche Disruption and a Sustained Inflammation in the BM

42. Lymph Node Lesions

47. Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

48. Sequential Combination of FLAM and Venetoclax plus Azacitidine to Bridge to Cord Blood Transplantation in a Patient with Primary Induction Failure Acute Myeloid Leukemia

Catalog

Books, media, physical & digital resources